Hepatitis B Virus Reactivation In A Patient Treated with Alectinib

Article Information

Boussuges Martin, Foch Emilie*, Allou Nathalie, Moreau Diane, Andre Michel

Pneumologie, Centre Hospitalier Universitaire Felix Guyon, Allée des Topazes, Saint Denis, France

*Corresponding Author: Foch Emilie, Pneumologie, Centre Hospitalier Universitaire Felix Guyon, Allée des Topazes, Saint Denis, France

Received: 21 January 2020; Accepted: 07 April 2020; Published: 24 May 2021

Citation: Boussuges Martin, Foch Emilie, Allou Nathalie, Moreau Diane, Andre Michel. Hepatitis B Virus Reactivation In A Patient Treated with Alectinib. Archives of Clinical and Medical Case Reports 5 (2021): 466-467.

Share at Facebook

Keywords

Lung adenocarcinoma; ALK gene rearrangement; Alectinib; Hepatitis B virus reactivation

Lung adenocarcinoma articles; ALK gene rearrangement articles; Alectinib articles; Hepatitis B virus reactivation articles

Lung adenocarcinoma articles Lung adenocarcinoma Research articles Lung adenocarcinoma review articles Lung adenocarcinoma PubMed articles Lung adenocarcinoma PubMed Central articles Lung adenocarcinoma 2023 articles Lung adenocarcinoma 2024 articles Lung adenocarcinoma Scopus articles Lung adenocarcinoma impact factor journals Lung adenocarcinoma Scopus journals Lung adenocarcinoma PubMed journals Lung adenocarcinoma medical journals Lung adenocarcinoma free journals Lung adenocarcinoma best journals Lung adenocarcinoma top journals Lung adenocarcinoma free medical journals Lung adenocarcinoma famous journals Lung adenocarcinoma Google Scholar indexed journals ALK gene rearrangement articles ALK gene rearrangement Research articles ALK gene rearrangement review articles ALK gene rearrangement PubMed articles ALK gene rearrangement PubMed Central articles ALK gene rearrangement 2023 articles ALK gene rearrangement 2024 articles ALK gene rearrangement Scopus articles ALK gene rearrangement impact factor journals ALK gene rearrangement Scopus journals ALK gene rearrangement PubMed journals ALK gene rearrangement medical journals ALK gene rearrangement free journals ALK gene rearrangement best journals ALK gene rearrangement top journals ALK gene rearrangement free medical journals ALK gene rearrangement famous journals ALK gene rearrangement Google Scholar indexed journals Alectinib articles Alectinib Research articles Alectinib review articles Alectinib PubMed articles Alectinib PubMed Central articles Alectinib 2023 articles Alectinib 2024 articles Alectinib Scopus articles Alectinib impact factor journals Alectinib Scopus journals Alectinib PubMed journals Alectinib medical journals Alectinib free journals Alectinib best journals Alectinib top journals Alectinib free medical journals Alectinib famous journals Alectinib Google Scholar indexed journals Hepatitis B virus reactivation articles Hepatitis B virus reactivation Research articles Hepatitis B virus reactivation review articles Hepatitis B virus reactivation PubMed articles Hepatitis B virus reactivation PubMed Central articles Hepatitis B virus reactivation 2023 articles Hepatitis B virus reactivation 2024 articles Hepatitis B virus reactivation Scopus articles Hepatitis B virus reactivation impact factor journals Hepatitis B virus reactivation Scopus journals Hepatitis B virus reactivation PubMed journals Hepatitis B virus reactivation medical journals Hepatitis B virus reactivation free journals Hepatitis B virus reactivation best journals Hepatitis B virus reactivation top journals Hepatitis B virus reactivation free medical journals Hepatitis B virus reactivation famous journals Hepatitis B virus reactivation Google Scholar indexed journals virus reactivation articles virus reactivation Research articles virus reactivation review articles virus reactivation PubMed articles virus reactivation PubMed Central articles virus reactivation 2023 articles virus reactivation 2024 articles virus reactivation Scopus articles virus reactivation impact factor journals virus reactivation Scopus journals virus reactivation PubMed journals virus reactivation medical journals virus reactivation free journals virus reactivation best journals virus reactivation top journals virus reactivation free medical journals virus reactivation famous journals virus reactivation Google Scholar indexed journals treatment articles treatment Research articles treatment review articles treatment PubMed articles treatment PubMed Central articles treatment 2023 articles treatment 2024 articles treatment Scopus articles treatment impact factor journals treatment Scopus journals treatment PubMed journals treatment medical journals treatment free journals treatment best journals treatment top journals treatment free medical journals treatment famous journals treatment Google Scholar indexed journals CT articles CT Research articles CT review articles CT PubMed articles CT PubMed Central articles CT 2023 articles CT 2024 articles CT Scopus articles CT impact factor journals CT Scopus journals CT PubMed journals CT medical journals CT free journals CT best journals CT top journals CT free medical journals CT famous journals CT Google Scholar indexed journals cholestasis articles cholestasis Research articles cholestasis review articles cholestasis PubMed articles cholestasis PubMed Central articles cholestasis 2023 articles cholestasis 2024 articles cholestasis Scopus articles cholestasis impact factor journals cholestasis Scopus journals cholestasis PubMed journals cholestasis medical journals cholestasis free journals cholestasis best journals cholestasis top journals cholestasis free medical journals cholestasis famous journals cholestasis Google Scholar indexed journals Abdominal surgery articles Abdominal surgery Research articles Abdominal surgery review articles Abdominal surgery PubMed articles Abdominal surgery PubMed Central articles Abdominal surgery 2023 articles Abdominal surgery 2024 articles Abdominal surgery Scopus articles Abdominal surgery impact factor journals Abdominal surgery Scopus journals Abdominal surgery PubMed journals Abdominal surgery medical journals Abdominal surgery free journals Abdominal surgery best journals Abdominal surgery top journals Abdominal surgery free medical journals Abdominal surgery famous journals Abdominal surgery Google Scholar indexed journals lymphadenopathy articles lymphadenopathy Research articles lymphadenopathy review articles lymphadenopathy PubMed articles lymphadenopathy PubMed Central articles lymphadenopathy 2023 articles lymphadenopathy 2024 articles lymphadenopathy Scopus articles lymphadenopathy impact factor journals lymphadenopathy Scopus journals lymphadenopathy PubMed journals lymphadenopathy medical journals lymphadenopathy free journals lymphadenopathy best journals lymphadenopathy top journals lymphadenopathy free medical journals lymphadenopathy famous journals lymphadenopathy Google Scholar indexed journals

Article Details

1. Background

Alectinib 600 mg twice daily is the first-line treatment for advanced lung adenocarcinoma with ALK gene rearrangement [1]. Elevation of liver enzymes up to acute hepatitis is a known side effect of the drug [2]. Here, we report a case of hepatitis B virus reactivation in a patient treated with alectinib.

2. Case Report

A 50-year-old man was hospitalized for left hemiplegia on day 1. The radiological assessment revealed a pulmonary mass in the left lower lobe along with secondary brain and kidney lesions. Biopsies showed an adenocarcinoma of the lung with ALK gene rearrangement. Treatment with alectinib was initiated on day 131. After two months of treatment, there was a near-complete regression of neurological disorders and the radiological reassessment showed a partial response based on RECIST criteria. The patient was readmitted to hospital on day 208 (two and a half months after the start of treatment) following the appearance of grade 3 cytolysis. Liver ultrasound did not reveal any abnormalities. Treatment with alectinib was discontinued based on current recommendations. Despite discontinuation of treatment, the hepatic assessment showed grade 4 cytolysis in association with cholestasis and an increase in conjugated bilirubin (aspartate aminotransferase 16N, alanine aminotransferase 19N, gamma-glutamyltranspeptidase 3N, slightly increased alkaline phosphatase, and conjugated bilirubin 2N). Pre-therapy assessment showed positive hepatitis B serology with positive anti-HBc Ac and HBsAg, but revealed no hepatic abnormalities. The hepatitis B viral load was assessed and was found to be very high (3.56^7 IU/ml). Treatment with tenofovir was initiated.

3. Discussion

Several cases of hepatitis B virus reactivation due to the introduction of immunosuppressive treatment such as rituximab have been described in the literature [3]. The treatment decision is based on risk stratification. In view of this, many health institutions recommend routine HBsAg and anti-HBc Ac screening before the introduction of immunosuppressive or cytotoxic treatment [4]. To date, no case of hepatitis B virus reactivation has been reported in patients receiving targeted therapy, including alectinib. The present case suggests the need for routine hepatitis B screening before the introduction of alectinib treatment and for prophylactic antiviral treatment in patients with non-active chronic hepatitis B.

References

  1. Solange Peters, D Ross Camidge, Alice T Shaw, et al. Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer. N Engl J Med 377 (2017): 829-838.
  2. Viola W Zhu, Yuxin Lu, Sai-Hong Ignatius Ou. Severe Acute Hepatitis in a Patient Receiving Alectinib for ALK-Positive Non–Small-Cell Lung Cancer: Histologic Analysis. Clin Lung Cancer 20 (2019): e77-e80.
  3. Nicolas Goossens, Francesco Negro. Reactivation of hepatitis B during immunosuppression. Rev Med Suisse 9 (2013): 1566-1571.
  4. Myint A, Tong MJ, Beaven SW. Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines. Clin Liver Dis (Hoboken) 15 (2020): 162-167.

© 2016-2024, Copyrights Fortune Journals. All Rights Reserved